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Abstract
Background. For over 50 years, radiocephalic wrist arte-
riovenous fistulae (RCAVF) have been the primary and
best vascular access for haemodialysis. Nevertheless, early
failure due to thrombosis or non-maturation is a major
complication resulting in their abandonment. This pro-
spective study was designed to investigate the predictive
value of intra-operative blood flow on early failure of pri-
mary RCAVF before the first effective dialysis.
Methods. We enrolled patients undergoing creation of
primary RCAVF for haemodialysis based on the pre-
operative ultrasound vascular mapping discussed in a
multidisciplinary approach. Intra-operative blood flow
measurement was systematically performed once the anas-
tomosis had been completed using a transit-time ultrasonic
flowmeter. During the follow-up, blood flow was esti-
mated by colour flow ultrasound at various intervals.
Any events related to the RCAVF were recorded.
Results. Autogenous RCAVFs (n = 58) in 58 patients were
constructed and followed up for an average of 30days.
Thrombosis and non-maturation occurred in eight (14%)
and four (7%) patients, respectively. The intra-operative
blood flow in functioning RCAVFs was significantly high-
er compared to non-functioning RCAVFs (230 vs 98mL/
min; P = 0.007), as well as 1week (753 vs 228mL/min;
P = 0.0008) and 4weeks (915 vs 245mL/min, P <
0.0001) later. Blood flow volume measurements with a
cut-off value of 120mL/min had a sensitivity of 67%,
specificity of 75% and positive predictive value of 91%.
Conclusions. Blood flow <120mL has a good predictive
value for early failure in RCAVF. During the procedure,
this cut-off value may be used to select appropriately
which RCAVF should be investigated in the operation the-
atre in order to correct in real time any abnormality.
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Introduction
For over 50years, radiocephalic arteriovenous fistula
(RCAVF) has demonstrated unquestionable superiority
over all other types of vascular access for haemodialysis
[1]. The main benefits of arteriovenous fistula (AVF) are
better long-term patency and lower complication rate. Nev-
ertheless, failure within the first 4 months after surgery oc-
curs in 20% to 50% of AVF [1–11]. Early failure of AVF is
defined as occlusion or insufficient development to sup-
port haemodialysis within the first 3months [12]. Matura-
tion of an AVF depends on flow volume and diameter of
the vein used for cannulation. In this regard, Robbin et al.
showed that the likelihood of sufficient growth was 95% if
flow volume was 500mL/min or greater in association with
a diameter of 4mm [13]. In most successful AVF, these
flow and size parameters are generally met within the first
few weeks after construction [12].
Several pre-operative factors have been shown to predict
the risk for early AVF failure. The main predictors are the
diameters of the artery and vein. Pre-operative ultrasound
(US) mapping is a useful tool for the accurate measure-
ment of vessel diameter as a basis for planning operative
strategy. Female gender and diabetes may also be risk fac-
tors for early AVF failure. In the scoring system proposed
by Lok et al. to predict failure to mature of AVF, the four
main clinical predictors were age over 65, peripheral or
coronary artery disease and white race [14]. During surgi-
cal exploration, the operator should take into account the
quality and size of the artery and the vein when deciding
whether or not to create the fistula at the site chosen during
pre-operative workup.
Few studies have evaluated intra-operative factors to
predict early failure immediately after construction of an
AVF. Two previous studies evaluated the predictive value
of intra-operative blood flow volume. Wong et al. were un-
able to demonstrate a link between intra-operative flow
volume and the risk of early occlusion [10]. On the other
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hand, Johnson et al. showed that the failure risk was sig-
nificantly higher if flow volume was less than 170mL/min
[15]. However, none of these studies were specifically
aimed to assess the value of intra-operative blood flow
measurements for the outcome of RCAVF. The purpose
of this study was thus to investigate the value of intra-
operative blood flow measurements in the prediction
for early failure and/or adequate function of RCAVF in
a cohort of patients about to start a chronic haemodialy-
sis program in our institution.
Materials and methods
Between January 2005 and December 2007, we performed 120 first-time
AVF including 67 RCAV, i.e. 56% of the total number. The study cohort
included a total of 58 patients that benefited from a first-time RCAVF;
nine patients were not included due to their previous vascular access by
central venous catheter. The criteria for inclusion were indication for ini-
tial haemodialysis requiring first-time AVF and complete follow-up data
up to the time of the first functioning dialysis. Follow-up was discontin-
ued at the time of the first functioning haemodialysis but never exceeded
8weeks. The functioning RCAVF was defined as the ability to use the
fistula for dialysis with two needles and maintain a dialysis machine
blood flow rate adequate for optimal dialysis (≥300mL/min) according
to the Dialysis Consortium Study (DAC) criteria [16]. During the fol-
low-up, the occlusions and the RCAVF unable to reach DAC's criteria
were defined as non-functioning. In accordance with our department's fol-
low-up policy for patients undergoing AVF for haemodialysis, all cases
were reviewed weekly at multidisciplinary staff meetings attended by
the nephrologist, angiologist, radiologist, vascular surgeon and dialysis
nurse. All patients underwent a pre-operative vascular mapping by means
of duplex ultrasound.
Pre-operative physical examination
The upper limb, shoulder and neck were examined to detect any sign of
previous trauma, muscle atrophy, venous hypertension related to proximal
vein obstruction or chronic ischaemia. Pulses were palpated, and an Allen
test was performed. Auscultation was focused on the neck as well as the
subclavian and axillary spaces.
Pre-operative duplex ultrasound examination
Duplex US was performed by experienced clinicians from the vascular
medicine department using 5 to 12MHz linear transducers (Envisor and
HDI 5000, Philips Medical Systems Switzerland, Gland, Switzerland;
Vingmed System V, GE Medical Systems Switzerland, Glattbrugg, Swit-
zerland). The arterial tree was assessed from the clavicle down to the
wrist. Vessel diameters and anatomical variations were noted. Spectral
Doppler waveforms were obtained at different levels. Presence of arterial
plaque was recorded regardless of whether resulting narrowing was hae-
modynamically significant or not. The extent of diffuse vessel wall calci-
fication was subjectively evaluated based on the echogenicity of vessel
walls and graded as follows: (i) no sign of diffuse calcification; (ii) mild
calcification causing increased echogenicity of vessel walls and shadowing
as observed in the transverse plane; (iii) moderate calcification causing
not only shadowing but also Doppler attenuation resulting in incomplete
luminal filling using colour mode; and (iv) severe calcification with high
echogenicity, marked shadowing and Doppler attenuation causing colour
to be nearly absent or to fill only very short segments of the artery, show-
ing a patchy pattern.
The anteroposterior diameters of the superficial veins and distal part
of the brachial veins were measured in the transverse plane after inflation
of a pressure cuff positioned as on the arm to 80–90mmHg to interrupt
venous return and induce maximal distal vein distension. Thrombosis of
draining veins was detected by B-mode imaging and compression. Dopp-
ler waveforms of the internal jugular and subclavian or axillary veins
were analysed. Proximal venous obstruction was considered as highly un-
likely in patients presenting the following three criteria: Doppler waves in
both internal jugular and subclavian veins exhibiting clear respiratory and
cardiac phasicity with the maximal velocity curve crossing the zero line;
absence of clinical signs such as distended veins and visible collaterals
especially around the neck, the shoulder and along the trunk; and normal
vein compressibility based on subjective assessment using the ultrasound
probe in B-mode.
After completing the US examination, findings were used to map the
anatomical features of vessels including not only course and diameter but
also the location of any abnormalities (plaque, stenosis and occlusions),
degree of wall calcification and characteristics of proximal venous flow.
Using this map, the clinician proposed the most suitable site for AVF con-
struction. The preferred minimal vein and artery diameters for RCAVF
creation were 2.5 and 2.0mm, respectively [9]. However, these size pre-
ferences were waived in some cases, e.g. young patients for whom slightly
smaller vessels were sometimes used and patients with a high degree of
arterial wall calcification for whom the artery size cut-off value was in-
creased to 3.0mm.
Surgical technique
All procedures were performed under local or regional anaesthesia using a
same standardized technique for creation of AVF, i.e. the minimal touch
technique with limited dissection of the cephalic vein and radial artery.
The artery was clamped using a coronary artery clamp, and an end-to-side
anastomosis was made using a continuous 7.0 polypropylene suture. Su-
turing was visualized through magnifying loupes (×3.5). At the operator's
discretion, papaverine was used after clamp removal if there were signs of
vasospasm. Systemic or local heparinization was not used. The patients
were operated on by a single vascular surgeon or senior resident super-
vised by this surgeon.
Intra-operative measurement of blood flow volume
Intra-operative measurement of blood flow volume was systematically
performed immediately after the construction of the AVF. In the case of
vasospasm requiring the use of papaverine, the measurement was delayed
for 5min. Measurements were performed by placing a 3–4mm handheld
flowprobe (MediStim, Oslo, Norway) around the draining vein 2cm
downstream from the anastomosis. Direct readings in mL/min were re-
corded after stabilization for 30 s. At least three readings were made until
consistent values were obtained usually within the first 5 min. Systolic
and diastolic pressure was recorded concomitantly with flow volume
measurements. All data were consigned to a dedicated study form imme-
diately after the procedure.
Post-operative ultrasound
Post-operative US was performed at each follow-up examination at 1
week, 1month and just prior to the first RCAVF cannulation. Blood flow
was assessed by measuring mean flow velocity and luminal diameter in
separate segments of brachial, ulnar, pre-anastomotic and post-anastomot-
ic radial arteries. Spectral Doppler and mean velocity were obtained with
a Doppler angle at 60° and a sample size covering the entire lumen. Ac-
cess blood flow was then calculated by adding pre-anastomotic radial to
post-anastomotic radial flow, in case of retrograde flow in the latter. If
post-anastomotic radial flow was antegrade, it was subtracted from pre-
anastomotic flow. During Doppler sonography, blood pressure was re-
corded several times on the controlateral arm by means of an automated
oscillometric manometer.
After access blood flow determination, feeding arteries and draining
veins as well as the anastomosis were checked for the presence of steno-
ses. First, a colour Doppler scan of arteries from the clavicle down to the
anastomosis was performed while analysing any flow disturbance by
spectral Doppler to obtain peak systolic velocity. The same was done
for the veins, from the anastomosis up to the clavicle and internal jugular
vein. Then, a precise B-mode image of each stenosis detected by colour
Doppler was obtained, and minimal luminal diameter was measured.
Study results were consigned to a dedicated form indicating access flow,
mean systolic and diastolic blood pressures and a vascular map of the
entire limb showing flow direction, vessel diameters and any stenosis with
its peak systolic velocity and minimal luminal diameter.
Statistical analysis
Statistical analysis was performed using Stata version 9.2 (StataCorp, Col-
lege Station, TX, USA). Results were expressed either as number of pa-
tients (percentage) or as mean (± standard deviation). Between-group
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comparisons were performed using the Wilcoxon test for quantitative data
and Fisher's exact test for qualitative data. Threshold values were screened
using the roctg function of Stata with 25mL/min blood flow volume in-
tervals. Specificity, sensitivity and predictive values were computed to-
gether with the respective 95% confidence intervals using the diatg
function of Stata. A P value less than 0.05 was considered as statistically
significant.
Results
Patient data including demographic characteristics, surgi-
cal findings, vessel diameters and comorbid conditions
are presented in Table 1. The mean age of patients was
63 ± 14.3years with 38% over the age of 70years.
The mean duration of follow-up was 30days (range, 15
to 45days; median, 21days). During follow-up, one patient
(1.7%) died at home from causes unrelated to the RCAVF,
and 12 patients (20.6%) presented events related to the
RCAVF, i.e. either failure to mature in four cases or perma-
nent occlusion in eight cases. All eight occlusions occurred
within the first post-operative week (mean delay, 3.3days;
range, 1-6days). In all cases, alternative vascular access
sites were created in more proximal locations including ip-
silateral brachiocephalic AVF in 63% and placement of a
prosthetic loop on the forearm in 37%. Placement of a per-
manent dialysis catheter was necessary in four of the eight
patients (50%) with inadequate RCAVF.
Table 2 compares patients who presented no events with
patients who presented early failure due to occlusion or
failure to mature. Female gender and low intra-operative
flow volume were significantly associated with early fail-
ure. To gain further insight on the impact of female gender,
the overall data were compared by gender (Table 3). Find-
ings showed that the artery diameter was significantly
smaller in women than men: 2.6±0.5 vs 3.0±0.6mm, re-
spectively (P = 0.03). The post-operative blood flow after
4weeks was also statistically higher in men (P = 0.02).
Vessel wall calcifications were identified in three patients
(16%) in the non-functioning RCAVF and six (15%) in the
functioning RCAVF group.
Flow measurements in all patent RCAVF at 1 month af-
ter the creation demonstrated a mean flow volume of 733±
296mL/min, i.e. a mean increase of 261% in comparison
with intra-operative findings. Figure 1 shows that during
the f irst post-operative month, the non-functioning
RCAVF flow volume only increased by 142% from 101±
87 to 245±412mL/min, whereas blood flow of functioning
RCAVF demonstrated an increase of 294% from 232 ± 194
to 915 ± 353mL/min. The increase of blood flow developed
mainly during the first post-operative week. Indeed, in the
functioning RCAVF, the blood flow increased by 224%
from 232 ± 194 to 753 ± 269mL/min, and only by 125%
fromWeeks 1 to 4. These kinetics also occurred in the non-
functioning RCAVF with an increase of 21% during the
first post-operative week and only 7% from Weeks 1 to 4.
Further analysis of flow volume data showed that the most
sensitive cut-off value to discriminate functioning and
non-functioning RCAVF was 120mL/min. Nine of the
12 non-functioning RCAVF (75%) presented flow vo-
lumes less than 120mL/min as compared to only 15 of
the 46 (32%) functioning RCAVF. A flow volume greater
than 120mL/min exhibited good sensitivity and specificity,
i.e. 67.4% (range, 51.9–80.5%) and 75% (range, 42.8–
94.5%), respectively. The positive predictive value of this
parameter was 91.2%, i.e. excellent (range, 76.3–98.1%).
The negative predictive value was, however, only 37.5%
(range; 18.8–59.4%).
Table 1. Demographic features, comorbidities, surgical findings and
vessel diameters in 58 patients who underwent first-time RCAVF
Variable Number (%)/mean ± SD
Age (year) 63 ± 14.3
Gender
Male 40 (69)
Female 18 (31)
Medical history
Hypertension 39 (67)
Diabetes 33 (57)
Current smoker 7 (12)
Ischaemic cardiac disease 18 (31)
Peripheral vascular disease 12 (20)
Anticoagulation 15 (25)
Antiaggregation 30 (51)
Intra-operative data
Intra-operative BF (mL/min) 203 ± 182
Artery diameter (mm) 2.9 ± 0.6
Vein diameter (mm) 3.1 ± 0.6
SBP (mmHg) 133 ± 24
DBP (mmHg) 76 ± 13
Papaverine 13 (22)
Left arm 38 (66)
BF, blood flow; SBP, systolic blood pressure; DBP, diastolic blood pressure.
Continuous variables are presented as mean ± standard deviation (SD) and
discrete variables as number with (percentage).
Table 2. Comparison of demographic features, surgical findings, vessel
diameters and comorbid conditions in 58 patients with non-functioning
(n = 12) and functioning (n = 46) RCAVF
Variable
Non-functioning
RCAVF
Functioning
RCAVF P value
n 12 46
Age (years) 57.5 ± 16.5 64.4 ± 13.5 0.12
Female gender 7 (58) 11 (24) 0.03
Medical history
Hypertension 10 (83) 29 (63) 0.3
Diabetes 10 (83) 23 (50) 0.06
Ischaemic cardiac disease 3 (25) 12 (26) 0.94
Peripheral vascular disease 3 (25) 9 (19) 0.68
Anticoagulation 4 (33) 11 (23) 0.51
Antiaggregation 8 (26) 22 (47) 0.25
Current smoker 1 (8) 6 (13) 0.1
Pre-operative data
Artery diameter (mm) 2.8 ± 0.6 2.9 ± 0.6 0.58
Vein diameter (mm) 2.9 ± 0.6 3.2 ± 0.8 0.21
Arterial calcification 5 (18) 12 (46) 0.83
Intra-operative data
BF (mL/min) 98 ± 65 230 ± 194 0.007
SBP (mmHg) 134 ± 25 137 ± 25 0.82
DBP (mmHg) 75 ± 13 78 ± 13 0.86
Other
Papaverine 3 (25) 10 (22) 1.00
Left arm 6 (50) 32 (70) 0.31
Local anaesthesia 13 (72) 32 (69) 0.51
BF, blood flow; SBP, systolic blood pressure; DBP, diastolic blood pressure.
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Discussion
Our findings demonstrate that the intra-operative measure-
ment of blood flow immediately after construction of a
RCAVF was useful to predict early AVF failure. Statistical
analysis identified a cut-off value of 120mL/min for dis-
criminating functioning and non-functioning RCAVF.
Johnson et al. reported that a high intra-operative flow vol-
ume defined as 320mL/min or greater was associated with
a lower number of surgical revisions and longer access sur-
vival regardless of gender, race or presence of diabetes.
The same authors reported that an intra-operative flow rate
of less than 170mL/min was correlated with a 56% risk for
AVF failure within the first 50days after construction [15].
In their 50-patient series, Won et al. also showed that an
intra-operative flow rate of less than 160mL/min was pre-
dictive of early failure of RCAVF [17]. A recent study in-
cluding a cohort of 109 patients undergoing vascular
access surgery for first-time haemodialysis showed that
an intra-operative flow rate greater than 200mL/min was
associated with better middle-term outcome in terms of re-
quirement for revision and early patency rate [18].
In this study, follow-up was limited to the period imme-
diately after construction of the RCAVF up to the first hae-
modialysis. The goal was to eliminate the effect of
puncture trauma associated with repeated puncture for ve-
nous access. This trauma may cause stenosis and/or hae-
morrhagic complications that are probably detrimental to
AVF patency. Previous authors reported longer follow-up
than ours but could not rule out the confounding effect of
haemodialysis-related injury on their results. Moreover,
the period prior to dialysis is crucial for AVF development
that appears to be correlated with flow volume. Immedi-
ately after AVF construction, flow volume increases rapid-
ly, reaching a maximum within 4 to 12weeks [10,19–22].
Between 40% and 60% of the total increase in flow vol-
ume occurs within 24 h after creation of the AVF
[10,19–22]. For most fistulas located on the forearm, max-
imum flow volume is reached within 4weeks after con-
struction [10,19]. The rate of the flow volume increase
depends partly on the diameter of the vein lumen. In an
earlier report, our group studied the size of the draining
vein and observed that the lumen increased 86% after 1
week and 179% after 12weeks in comparison with the lu-
men of the contralateral vein [22]. These results confirmed
a previous study involving AVF located on the forearm
that showed a 56% increase within the first 24h after con-
struction to 123% at 12weeks in comparison with controls
[10]. A fistula can be considered as mature or suitable to
support haemodialysis when it allows insertion of two nee-
dles and can provide sufficient blood flow, i.e. at least
350–450mL/min. Adequate flow volume is at least of
500mL/min for an AVF [23]. There is currently no con-
sensus as to criteria for predicting the outcome of AVF de-
velopment. Some authors wait as long as 3 to 4months
before declaring an AVF non-functioning [16,24].
Several studies have attempted to identify predictors of
AVF development. Pre-operative vascular mapping that we
have been using routinely for many years has been shown
to maximize the opportunities for autogenous fistulas and
lower the need for prosthetic fistulas [9,25]. However, a
reliable correlation has not been established between pre-
operative evidence of adequate artery and vein diameter
and AVF development [10,26,27]. A recent study [28] in-
dicated that measurement of vein compliance was a good
predictor of AVF development, but this finding was not
confirmed in two subsequent studies [21,29]. Post-opera-
tive measurement of blood flow volume by duplex US has
not been consistently shown to be useful in predicting AVF
development [30,31]. Our data showed that the increase in
flow volume during the first month after creation was
261% for functioning RCAVF as compared to only
142% for non-functioning RCAVF. This finding suggests
that there is a good correlation between rapid flow volume
increase in the first post-operative month and maturation
of the RCAVF. Intra-operative and post-operative measure-
ments showed that mean blood flow volume was signifi-
cantly higher in functioning than non-functioning RCAVF.
The intra-operative measurement of arterial dilation in re-
Table 3. Comparison of demographic features, comorbidities, surgical
findings and vessel diameters in men (n = 40) and women (n = 18)
Women Men P value
n 18 40
Age (years) 63.7 ± 17.3 62.6 ± 13 0.48
Medical history
Diabetes 11 (61) 22 (55) 0.78
Hypertension 13 (72) 26 (65) 0.76
Ischaemic cardiac disease 6 (33) 12 (30) 0.80
Peripheral vascular disease 4 (22) 8 (20) 0.85
Current smoker 2 (25) 5 (12) 0.88
Anticoagulation 5 (27) 10 (40) 0.82
Antiaggregation 9 (50) 21 (52) 0.86
Blood Flow
Intra-operative BF (mL/min) 142.7 ± 94.7 230.2 ± 205.6 0.13
Post-operative BF (mL/min) 513.6 ± 330.2 784.7 ± 278.9 0.02
Pre-operative diameter
Artery diameter (mm) 2.6 ± 0.5 3.0 ± 0.6 0.03
Vein diameter (mm) 3.1 ± 0.7 3.1 ± 1.0 0.99
Other
Papaverin 5 (27) 8 (20) 0.52
Left arm 11 (61) 27 (67) 0.77
BF, blood flow. Results are expressed as mean ± standard deviation or as
number of subjects and (percentage). Statistical analysis by Wilcoxon test
or Fisher's exact test.
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Fig. 1. Blood flow (in mL/min) in functioning (black box) and non-
functioning RCAVF (white box).
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sponse to reactive hyperaemia has also been identified as a
predictor for AVF development with a sensitivity of 95%,
a specificity of 61% and a positive predictive value of
87% [29]. In comparison, our results indicated that blood
flow volume measurements with a cut-off point of 120mL/
min had a sensitivity of 67%, specificity of 75% and pos-
itive predictive value of 91%.
In agreement with previous studies [32,33], our data also
showed that failure of an RCAVF to mature was frequently
associated with females. Comparison of vessel diameters
according to gender in our cohort demonstrated that arter-
ies were significantly smaller in women than in men.
However, it should be underlined that our findings are in
contradiction with two recent studies showing no signifi-
cant gender difference in the pre-operative diameters of
veins and arteries [32,34].
Failure of an AVF to mature can have many aetiologies
[35]. The most frequent cause is neointimal hyperplasia
typically occurring in the juxta-anastomotic vein. Hyper-
plasia develops during the first post-operative month. In
our study, all AVF occlusion occurred during the first
post-operative week. Possible explanations include a defect
in the surgical technique, poor vein quality or insufficient
vessel diameter that was incorrectly estimated during US
mapping. Pre-operative measurements should be made to
detect possible sources of insufficient flow volume. US
mapping could also decrease the functional maturation
rate by the increase in performing complex procedures
which were often secondary ones and by the use of smaller
vein only detected by US but invisible during upper limb
inspection [36]. Our vascular access improvement pro-
gram provides for increasing the rate of autogenous vascu-
lar access and decreasing early failure. Pre-operative US
mapping, early referral to vascular surgeon and surveil-
lance program are some of the measures to achieve these
goals. Despite the implementation of the Disease Out-
comes Quality Initiative (DOQI) guidelines in our institu-
tion, 12 (20%) RCAVF failed to mature or occluded. The
intra-operative surgical assessment of the vessels is the last
possibility to choose the right strategy. To detect technical
defects and identify poor artery or vein quality, Lin et al.
proposed performing fistulography during the same proce-
dure. The same authors pointed out that if a technical de-
fect requiring surgical correction was not found, careful
post-operative surveillance was necessary to allow early
detection and prompt treatment of possible problems.
They also proposed immediate construction of another
fistula in diabetic patients presenting intra-operative flow
volume less than 200mL/min [18]. Finally, Berman et al.
recommended that RCAVF with an intra-operative flow
rate of <120mL/min should either be immediately aban-
doned for another site or, at a minimum, evaluated for
an immediate revision [37]. In view of these results, we
intend to find out whether intra-operative haemodynamic
and anatomical criteria may directly impact on the deci-
sion-making process in patients awaiting a functional AVF.
Our study may have a direct implication for practical
clinical issue. Indeed, the intra-operative blood flow mea-
surement should be carried out after each procedure to get
a start value. A blood flow <120mL/min has a good pre-
dictive value of early failure. This implies that we should
aim for intra-operative investigations in order to look for a
possible reason for this low blood flow. For instance, a fis-
tulography with potentially a subsequent interventional
procedure to re-establish a higher blood flow may be pro-
posed. This hypothesis will be tested in a further study in
our institution. In contrast, an intra-operative blood flow
>120ml/min may be interpreted as a safe result in terms
of future RCAVF maturation. In conclusion, the findings
of this study indicated that the intra-operative measure-
ment of blood flow is a useful tool to predict the outcome
of maturation in first-time RCAVF. A simple transit-time
device can be used to obtain immediate readings that can
be used to adapt operative strategy and thus improve out-
come. These findings should be associated with blood flow
value measurement just before the first puncture which is
obviously an important criterion for making a decision.
Whether this can be used to modify the intra-operative
strategy, thus reducing the failure-to-mature rate, needs to
be investigated.
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Abstract
Background. In children, growth can be used as a measur-
able parameter of adequate nutrition and dialysis dose. De-
spite daily administration of recombinant human growth
hormone (rhGH), growth retardation remains a frequent
problem in children on chronic dialysis. Therefore, we per-
formed an observational prospective non-randomized study
of children on in-centre daily on line haemodiafiltration (D-
OL-HDF) dialysis with the aim of promoting growth.
Patients and methods. Mean age at the start of the study
was 8 years and 3 months, and all children had been receiv-
ing rhGH treatment for >12months before enrolment.Mean
follow-up time on D-OL-HDF was 20.5 ± 8 months (range,
11–39 months). Renal residual function was either <3 mL/
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